IRIS Accounts Production v25.1.4.42 01438896 Board of Directors 1.11.23 31.10.24 31.10.24 Medium entities true false true true false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Voting 1.00000 Non-voting 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh014388962023-10-31014388962024-10-31014388962023-11-012024-10-31014388962022-10-31014388962022-11-012023-10-31014388962023-10-3101438896ns15:EnglandWales2023-11-012024-10-3101438896ns14:PoundSterling2023-11-012024-10-3101438896ns10:Director12023-11-012024-10-3101438896ns10:PrivateLimitedCompanyLtd2023-11-012024-10-3101438896ns10:MediumEntities2023-11-012024-10-3101438896ns10:Audited2023-11-012024-10-3101438896ns10:Medium-sizedCompaniesRegimeForDirectorsReport2023-11-012024-10-3101438896ns10:Medium-sizedCompaniesRegimeForAccounts2023-11-012024-10-3101438896ns10:FullAccounts2023-11-012024-10-3101438896ns10:OrdinaryShareClass12023-11-012024-10-3101438896ns10:OrdinaryShareClass22023-11-012024-10-3101438896ns10:Director22023-11-012024-10-3101438896ns10:Director32023-11-012024-10-3101438896ns10:Director42023-11-012024-10-3101438896ns10:Director52023-11-012024-10-3101438896ns10:Director62023-11-012024-10-3101438896ns10:Director72023-11-012024-10-3101438896ns10:Director82023-11-012024-10-3101438896ns10:Director92023-11-012024-10-3101438896ns10:CompanySecretary12023-11-012024-10-3101438896ns10:RegisteredOffice2023-11-012024-10-3101438896ns5:CurrentFinancialInstruments2024-10-3101438896ns5:CurrentFinancialInstruments2023-10-3101438896ns5:ShareCapital2024-10-3101438896ns5:ShareCapital2023-10-3101438896ns5:RetainedEarningsAccumulatedLosses2024-10-3101438896ns5:RetainedEarningsAccumulatedLosses2023-10-3101438896ns5:ShareCapital2022-10-3101438896ns5:RetainedEarningsAccumulatedLosses2022-10-3101438896ns5:RetainedEarningsAccumulatedLosses2022-11-012023-10-3101438896ns5:RetainedEarningsAccumulatedLosses2023-11-012024-10-3101438896ns5:LandBuildingsns5:OwnedOrFreeholdAssets2023-11-012024-10-3101438896ns5:LeaseholdImprovements2023-11-012024-10-3101438896ns5:PlantMachinery2023-11-012024-10-3101438896ns5:FurnitureFittings2023-11-012024-10-3101438896ns5:MotorVehicles2023-11-012024-10-310143889612023-11-012024-10-3101438896ns15:UnitedKingdom2023-11-012024-10-3101438896ns15:UnitedKingdom2022-11-012023-10-3101438896ns15:Europe2023-11-012024-10-3101438896ns15:Europe2022-11-012023-10-3101438896ns15:UnitedStates2023-11-012024-10-3101438896ns15:UnitedStates2022-11-012023-10-3101438896ns15:SouthAmerica2023-11-012024-10-3101438896ns15:SouthAmerica2022-11-012023-10-3101438896ns15:Asia2023-11-012024-10-3101438896ns15:Asia2022-11-012023-10-3101438896ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2023-11-012024-10-3101438896ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2022-11-012023-10-3101438896ns10:HighestPaidDirector2023-11-012024-10-3101438896ns10:HighestPaidDirector2022-11-012023-10-3101438896ns5:OwnedAssets2023-11-012024-10-3101438896ns5:OwnedAssets2022-11-012023-10-3101438896122023-11-012024-10-3101438896122022-11-012023-10-310143889652023-11-012024-10-310143889652022-11-012023-10-3101438896ns5:HirePurchaseContracts2023-11-012024-10-3101438896ns5:HirePurchaseContracts2022-11-012023-10-3101438896ns10:OrdinaryShareClass12022-11-012023-10-3101438896ns5:LandBuildings2023-10-3101438896ns5:LeaseholdImprovements2023-10-3101438896ns5:PlantMachinery2023-10-3101438896ns5:LandBuildings2023-11-012024-10-3101438896ns5:LandBuildings2024-10-3101438896ns5:LeaseholdImprovements2024-10-3101438896ns5:PlantMachinery2024-10-3101438896ns5:LandBuildings2023-10-3101438896ns5:LeaseholdImprovements2023-10-3101438896ns5:PlantMachinery2023-10-3101438896ns5:FurnitureFittings2023-10-3101438896ns5:MotorVehicles2023-10-3101438896ns5:FurnitureFittings2024-10-3101438896ns5:MotorVehicles2024-10-3101438896ns5:FurnitureFittings2023-10-3101438896ns5:MotorVehicles2023-10-3101438896ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-3101438896ns5:WithinOneYearns5:CurrentFinancialInstruments2023-10-3101438896ns5:DeferredTaxation2023-10-3101438896ns5:DeferredTaxation2023-11-012024-10-3101438896ns5:DeferredTaxation2024-10-3101438896ns10:OrdinaryShareClass12024-10-3101438896ns10:OrdinaryShareClass22024-10-3101438896ns5:RetainedEarningsAccumulatedLosses2023-10-31
REGISTERED NUMBER: 01438896 (England and Wales)












CELTIC CHEMICALS LIMITED

STRATEGIC REPORT,

REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31 OCTOBER 2024






CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024




Page

Company Information 1

Strategic Report 2

Report of the Directors 4

Report of the Independent Auditors 6

Income Statement 9

Other Comprehensive Income 10

Balance Sheet 11

Statement of Changes in Equity 12

Cash Flow Statement 13

Notes to the Cash Flow Statement 14

Notes to the Financial Statements 15


CELTIC CHEMICALS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 OCTOBER 2024







DIRECTORS: J M Donald
R Houlton
Mrs K P Woolcock
Mrs H M Donald
B J Donald
R D Woolcock
S M Houlton
Mrs H M Donald
J M Donald





SECRETARY: J M Donald





REGISTERED OFFICE: Unit 25 Kenfig Industrial Estate
Margam
Port Talbot
SA13 2PE





REGISTERED NUMBER: 01438896 (England and Wales)





AUDITORS: Bevan Buckland LLP (Statutory Auditors)
Ground Floor Cardigan House
Castle Court
Swansea Enterprise Park
Swansea
SA7 9LA

CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

STRATEGIC REPORT
FOR THE YEAR ENDED 31 OCTOBER 2024

The directors present their strategic report for the year ended 31 October 2024.

REVIEW OF BUSINESS
The trading activities of the company continued with turnover decreasing slightly from last year however remaining fairly consistent. Gross Profit Margin remains at an acceptable level.


2024 2023 2022
Turnover £'000 13,094 12,312 13,544
Gross Profit Margin 37.69% 38.65% 35.52%

Average Number of Employees 32 29 31


KEY PERFORMANCE INDICATORS
The directors carefully monitor results and consider that the company's key performance indicators are financial, namely turnover and operating profit. These are reflected in the financial statements.

FUTURE PLANS
The directors consider the financial position of the company at the Balance Sheet date to be satisfactory and expects the current level of activity to be sustained for the foreseeable future.

PRINCIPAL RISKS AND UNCERTAINTIES
The directors regularly review the principal risks facing the company including those that would impact its business model, future performance, and solvency. The directors ensure that the nature and extent of significant risks facing the business are identified and adequately managed.

The company uses various financial instruments which include cash and various items such as trade debtors and trade creditors that arise directly from its operations. The main purpose of these financial instruments is to raise finance for the company's operations.

There continues to be a focus on identifying and assessing potential emerging risks. These can be newly identified risks or known risks that have evolved. The directors' horizon scan to ensure they can take appropriate actions against potential changes that could change the industry or the business from a risk and opportunity perspective.

The directors will continually monitor the principal and other risks and uncertainties for the business. The directors will closely monitor business performance, including using monthly key performance indicators, and will take appropriate action, including amendments to its business model, if required.

The following are the risks the directors believe to be the most important risks and uncertainties that may impact on the company's ability to deliver its strategy effectively.

Liquidity risk
The company seeks to manage financial risk by ensuring sufficient liquidity is available to meet foreseeable needs and to invest cash assets safely and profitably.

Credit risk
The company's principal financial assets are cash and trade debtors. The principal credit risk arises from its trade debtors. To manage credit risk, the directors set limits for customers based on a combination of payment history and third-party credit references. Credit limits are reviewed by the credit controller on a regular basis in conjunction with debt ageing and collection history.

Interest rate risk
The company has limited its interest rate risk by continuing to hold sufficient cash balances to meet its needs without the need for further financing.

Cash flow risk
The company holds significant cash reserves to mitigate against cash flow difficulties.

Trading Risks
(i) Current economic climate:
Recent inflation in the UK (and subsequent weakening of the Pound) has driven up the cost of acquiring stock items and inevitably wages. The directors continually review purchasing and investment strategies and pricing structure to mitigate this risk. The reduction in shipping costs is helping to compensate for the increase in costs.


CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

STRATEGIC REPORT
FOR THE YEAR ENDED 31 OCTOBER 2024

HEALTH AND SAFETY
Celtic Chemicals Limited takes Health & Safety issues seriously and is committed to protecting the health and safety of its staff and others affected by its business activities and attending its premises. To this end the company publishes a 'Health and Safety Policy' that clearly outlines the responsibilities of Directors & Staff in issues of H&S. To facilitate adherence to the policy, risk assessments are conducted with actions set.

In the year ending 31st October 2024, two health and safety non-conformances were recorded, none of which were subject to mandatory recording or reporting under RIDDOR 2013. Both were classified internally as 'minor' incidents.

ENVIRONMENT
As a manufacturer and trader of minerals and metals for the various industries, Celtic Chemicals Ltd is committed to "Protecting today's environment for tomorrow's needs".

Senior management at Celtic Chemicals Ltd recognises that company day to day operations we inevitably impact on the environment. They are committed to reducing that impact through continual improvement improved environmental performance. The company environmental policy is the overarching document that ensures this aim is fulfilled.

The company continues to operate within the limits set in its Natural Resources Wales Low Impact Installation permit. These environmental aspects form an integral part of the company's business strategy as it strives to make continual improvements. Environmental aspect monitored include,

- Energy efficiency
- Raw material use
- Avoidance, recovery, and disposal of wastes
- Emissions to air, water and land
- Odour
- Noise and vibration

In the year ending 31st October 2024 the company was compliant with all local and international laws and regulations relating to environmental aspects & there were no environmental non-conformances. The company made strides towards ISO1400, strengthening its commitment to environmental protection. The standard ensures continued adherence to local and international laws and regulations relating to environmental aspects. There were no environmental non-conformances in the period.

ETHICAL TRADING
Celtic Chemicals Limited recognises the responsibility that it shares with its suppliers to source, buy, produce, and sell products in an ethical manner. The company ethical trading policy requires that all suppliers comply with Celtic Chemicals' ethical code which is based on the International Labour Organisation (ILO) and national and international laws.
The CCL ethical trading code covers the following topics:

- Forced labour
- Child labour
- Discrimination
- Working conditions
- Remuneration
- Freedom of association
- Bribery

ON BEHALF OF THE BOARD:





R D Woolcock - Director


29 July 2025

CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 OCTOBER 2024

The directors present their report with the financial statements of the company for the year ended 31 October 2024.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of manufacturing and trading in industrial chemicals.

DIVIDENDS
Interim dividends of £5.90 per ordinary A share, £3.52 per ordinary voting share, and £3.52 per ordinary GBP share was paid on 31 October 2024.

Final dividends of £0.9833 per ordinary A share, £0.5866 per ordinary voting share, and £0.5866 per ordinary GBP share was paid on 23rd December 2024.

No dividend was payable on non voting shares.

The total distribution of dividends for the year ended 31 October 2024 was £611,566.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 November 2023 to the date of this report.

J M Donald
R Houlton
Mrs K P Woolcock
Mrs H M Donald
B J Donald
R D Woolcock
S M Houlton
Mrs H M Donald
J M Donald

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 OCTOBER 2024


AUDITORS
The auditors, Bevan Buckland LLP (Statutory Auditors), will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





R D Woolcock - Director


29 July 2025

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
CELTIC CHEMICALS LIMITED

Opinion
We have audited the financial statements of Celtic Chemicals Limited (the 'company') for the year ended 31 October 2024 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 October 2024 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
CELTIC CHEMICALS LIMITED


Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page four, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Identifying and assessing potential risks related to irregularities.
In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, our procedures included the following:

- enquiring of management, including obtaining and reviewing support documentation, concerning the company's policies and procedures relating to:
- identifying, evaluating, and complying with laws and regulations and whether they were aware of any instances of non-compliance;
- detecting and responding to the risks of fraud and whether they have knowledge of any actual, suspected or alleged fraud;
- internal controls established to mitigate risks related to fraud or non-compliance with laws and regulations;
- discussing among the engagement team how and where fraud might occur in the Financial Statements and any potential indicators of fraud.
- obtaining an understanding of the legal and regulatory frameworks that the company operates in, focusing on those laws and regulations that had a direct effect on the Financial Statements or that had a fundamental effect on the operations of the company, The key laws and regulations we considered in this context included the UK Companies Act and relevant tax legislation.

Audit response to risks identified
In addition to the above, our procedures to respond to risks identified included the following:

- reviewing the financial statement disclosures and testing to supporting documentation to assess compliance with relevant laws and regulations;
- enquiring of management concerning actual and potential litigation and claims; performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud;
- reading minutes of meetings of those charged with governance and reviewing correspondence with HMRC;
- in addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments;
- assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and
- evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.

We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
CELTIC CHEMICALS LIMITED


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Henry Lloyd Davies (Senior Statutory Auditor)
for and on behalf of Bevan Buckland LLP (Statutory Auditors)
Ground Floor Cardigan House
Castle Court
Swansea Enterprise Park
Swansea
SA7 9LA

29 July 2025

CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

INCOME STATEMENT
FOR THE YEAR ENDED 31 OCTOBER 2024

2024 2023
Notes £    £   

TURNOVER 4 13,094,118 12,312,045

Cost of sales 8,159,489 7,553,725
GROSS PROFIT 4,934,629 4,758,320

Administrative expenses 3,040,961 2,780,386
OPERATING PROFIT 6 1,893,668 1,977,934

Interest receivable and similar income 83,542 19,369
1,977,210 1,997,303

Interest payable and similar expenses 7 1,634 18
PROFIT BEFORE TAXATION 1,975,576 1,997,285

Tax on profit 8 496,778 452,849
PROFIT FOR THE FINANCIAL YEAR 1,478,798 1,544,436

CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 OCTOBER 2024

2024 2023
Notes £    £   

PROFIT FOR THE YEAR 1,478,798 1,544,436


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR
THE YEAR

1,478,798

1,544,436

CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

BALANCE SHEET
31 OCTOBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 10 914,847 697,748

CURRENT ASSETS
Stocks 11 2,479,151 1,976,646
Debtors 12 2,501,827 1,856,517
Cash at bank 3,405,101 3,840,404
8,386,079 7,673,567
CREDITORS
Amounts falling due within one year 13 2,477,487 2,474,572
NET CURRENT ASSETS 5,908,592 5,198,995
TOTAL ASSETS LESS CURRENT
LIABILITIES

6,823,439

5,896,743

PROVISIONS FOR LIABILITIES 14 108,391 48,927
NET ASSETS 6,715,048 5,847,816

CAPITAL AND RESERVES
Called up share capital 15 99,500 99,500
Retained earnings 16 6,615,548 5,748,316
SHAREHOLDERS' FUNDS 6,715,048 5,847,816

The financial statements were approved by the Board of Directors and authorised for issue on 29 July 2025 and were signed on its behalf by:





R D Woolcock - Director


CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 OCTOBER 2024

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 November 2022 99,500 5,252,278 5,351,778

Changes in equity
Dividends - (1,048,398 ) (1,048,398 )
Total comprehensive income - 1,544,436 1,544,436
Balance at 31 October 2023 99,500 5,748,316 5,847,816

Changes in equity
Dividends - (611,566 ) (611,566 )
Total comprehensive income - 1,478,798 1,478,798
Balance at 31 October 2024 99,500 6,615,548 6,715,048

CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 OCTOBER 2024

2024 2023
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 877,555 2,848,464
Interest paid (1,634 ) -
Interest element of hire purchase or finance
lease rental payments paid

-

(18

)
Tax paid (440,961 ) (631,440 )
Net cash from operating activities 434,960 2,217,006

Cash flows from investing activities
Purchase of tangible fixed assets (342,239 ) (244,762 )
Interest received 83,542 19,369
Net cash from investing activities (258,697 ) (225,393 )

Cash flows from financing activities
Capital repayments in year - (649 )
Equity dividends paid (611,566 ) (1,048,398 )
Net cash from financing activities (611,566 ) (1,049,047 )

(Decrease)/increase in cash and cash equivalents (435,303 ) 942,566
Cash and cash equivalents at beginning
of year

2

3,840,404

2,897,838

Cash and cash equivalents at end of year 2 3,405,101 3,840,404

CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

NOTES TO THE CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 OCTOBER 2024

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

2024 2023
£    £   
Profit before taxation 1,975,576 1,997,285
Depreciation charges 125,140 97,800
Finance costs 1,634 18
Finance income (83,542 ) (19,369 )
2,018,808 2,075,734
(Increase)/decrease in stocks (502,505 ) 793,905
(Increase)/decrease in trade and other debtors (645,310 ) 476,849
Increase/(decrease) in trade and other creditors 6,562 (498,024 )
Cash generated from operations 877,555 2,848,464

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 October 2024
31.10.24 1.11.23
£    £   
Cash and cash equivalents 3,405,101 3,840,404
Year ended 31 October 2023
31.10.23 1.11.22
£    £   
Cash and cash equivalents 3,840,404 2,897,838


3. ANALYSIS OF CHANGES IN NET FUNDS

At 1.11.23 Cash flow At 31.10.24
£    £    £   
Net cash
Cash at bank 3,840,404 (435,303 ) 3,405,101
3,840,404 (435,303 ) 3,405,101
Total 3,840,404 (435,303 ) 3,405,101

CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024

1. STATUTORY INFORMATION

Celtic Chemicals Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 2% on cost
Improvements to property - 15% on cost
Plant and Machinery - 20% straight line
Fixtures and fittings - 25% on cost and 10% on cost
Motor vehicles - 25% on cost

Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Costs, which comprise direct product costs are usually based on a first-in-first-out basis. Net realisable value is based on the estimated selling price less any estimated completion or selling costs.

When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of stock recognised as an expense in the period in which the reversal occurs.

CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2024

2. ACCOUNTING POLICIES - continued

Financial instruments
The company enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities such as trade and other receivables and payables.

Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.

Debt instruments like other receivables and payables are initially measured at present value of the future payments and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade payables or receivables, are measured, initially and subsequently, at the undiscounted amount of cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in case of an outright short-term loan not at market rate, the financial asset or liability is measured, initially and subsequently, at the present value of future payments discounted at a market rate of interest for a similar debt instrument.

Impairment of financial assets
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit or loss. For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying value and the present value of estimated cash flows discounted at the assets original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract. For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and the best estimate, which is an approximation, of the amount that the company would receive for the asset if it were to be sold at the reporting date.

Financial assets and liabilities are offset and the net amount recognised in the balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. At each reporting date non-financial assets not carried at fair value, such as property, plant and equipment are reviewed to determine whether there is an indication that an asset may be impaired. If there is an indication of possible impairment, the recoverable amount of any asset or group of related assets, which is the higher of value in use and the fair value less costs to sell, is estimated and compared with its carrying amount. If the recoverable amount is lower, the carrying amount of the asset is reduced to its recoverable amount and an impairment loss is recognised immediately in profit or loss.

If an impairment loss is subsequently reversed, the carrying amount of the asset or group of related assets is increased to the revised estimate of its recoverable amount, but not to exceed the amount that would have been determined had no impairment loss been recognised for the asset or group of related assets in prior periods. A reversal of an impairment loss is recognised immediately in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2024

2. ACCOUNTING POLICIES - continued

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Debtors
Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

Cash at bank and in hand
Cash at bank and cash in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

Creditors and provisions
Creditors and provisions are recognised where the company has a present obligation (legal and constructive) resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

3. CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY

In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Significant management judgements
The following are management judgements in applying the accounting policies of the company that have the most significant effect on the amounts recognised in the financial statements.

Economic Life
Tangible fixed assets are depreciated over their useful economic lives based on various internal and external factors. The actual lives of the assets are re-assessed on a periodic basis and may vary depending on the standard of the asset. The board periodically review the major classes of assets to ensure that the periods over which they are depreciated is appropriate.

Provisions and accruals
Management bases its judgement on the circumstances relating to each specific event and upon currently available information. However, given the inherent difficulties in the estimation of liabilities in these areas, it cannot be guaranteed that additional costs will not be incurred beyond the amounts accrued.

CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2024

4. TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the company.

An analysis of turnover by geographical market is given below:

2024 2023
£    £   
United Kingdom 8,194,471 7,998,962
Europe 3,679,465 2,927,524
United States of America 490,238 577,107
South America 28,909 45,264
Asia 526,473 693,858
Australia 114,306 14,154
Africa 56,164 54,826
New Zealand - 350
Other 4,092 -
13,094,118 12,312,045

5. EMPLOYEES AND DIRECTORS
2024 2023
£    £   
Wages and salaries 2,047,383 1,975,300
Social security costs 239,599 231,286
Other pension costs 58,360 65,253
2,345,342 2,271,839

The average number of employees during the year was as follows:
2024 2023

Management 3 3
Operations and quality 10 10
Sales and warehousing 7 7
Administration 3 4
Laboratory 2 2
Finance 2 1
Purchasing 1 2
28 29

2024 2023
£    £   
Directors' remuneration 1,191,644 1,230,274
Directors' pension contributions to money purchase schemes 30,000 42,846

The number of directors to whom retirement benefits were accruing was as follows:

Money purchase schemes 3 3

Information regarding the highest paid director is as follows:
2024 2023
£    £   
Emoluments etc 279,155 268,506
Pension contributions to money purchase schemes 10,432 10,846

CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2024

6. OPERATING PROFIT

The operating profit is stated after charging/(crediting):

2024 2023
£    £   
Depreciation - owned assets 125,140 97,802
Foreign exchange differences (7,318 ) (17,702 )
Fees payable to the company's auditors for the audit of the company's
financial statements

18,865

13,500

7. INTEREST PAYABLE AND SIMILAR EXPENSES
2024 2023
£    £   
Corporation tax interest 1,634 -
Hire purchase - 18
1,634 18

8. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2024 2023
£    £   
Current tax:
UK corporation tax 437,314 440,584

Deferred tax 59,464 12,265
Tax on profit 496,778 452,849

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2024 2023
£    £   
Profit before tax 1,975,576 1,997,285
Profit multiplied by the standard rate of corporation tax in the UK of 25%
(2023 - 25%)

493,894

499,321

Effects of:
Expenses not deductible for tax purposes 2,824 5,046
Adjustments to tax charge in respect of previous periods 60 (846 )

deferred tax
Effect of rate change - (50,672 )
Total tax charge 496,778 452,849

9. DIVIDENDS
2024 2023
£    £   
Voting shares of £1 each
Interim 611,566 1,048,398

CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2024

10. TANGIBLE FIXED ASSETS
Improvements
Freehold to Plant and
property property Machinery
£    £    £   
COST
At 1 November 2023 440,699 514,180 515,727
Additions - 236,089 99,479
At 31 October 2024 440,699 750,269 615,206
DEPRECIATION
At 1 November 2023 64,891 380,211 406,724
Charge for year 8,814 65,887 38,264
At 31 October 2024 73,705 446,098 444,988
NET BOOK VALUE
At 31 October 2024 366,994 304,171 170,218
At 31 October 2023 375,808 133,969 109,003

Fixtures
and Motor
fittings vehicles Totals
£    £    £   
COST
At 1 November 2023 321,176 - 1,791,782
Additions 979 5,692 342,239
At 31 October 2024 322,155 5,692 2,134,021
DEPRECIATION
At 1 November 2023 242,208 - 1,094,034
Charge for year 11,302 873 125,140
At 31 October 2024 253,510 873 1,219,174
NET BOOK VALUE
At 31 October 2024 68,645 4,819 914,847
At 31 October 2023 78,968 - 697,748

11. STOCKS
2024 2023
£    £   
Stocks 2,479,151 1,976,646

12. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 2,395,574 1,737,672
Consignment stocks 64,169 42,028
Other debtors 22,613 41,301
Prepayments 19,471 35,516
2,501,827 1,856,517

CELTIC CHEMICALS LIMITED (REGISTERED NUMBER: 01438896)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2024

13. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 1,183,488 436,353
Tax 216,937 220,584
Social security and other taxes 243,492 479,061
VAT 224,699 265,477
Other creditors 92,683 522,818
Accrued expenses 516,188 550,279
2,477,487 2,474,572

14. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 108,391 48,927

Deferred
tax
£   
Balance at 1 November 2023 48,927
Charge to Income Statement during year 59,464
Balance at 31 October 2024 108,391

15. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
97,500 Voting £1 97,500 97,500
2,000 Non-voting £1 2,000 2,000
99,500 99,500

16. RESERVES
Retained
earnings
£   

At 1 November 2023 5,748,316
Profit for the year 1,478,798
Dividends (611,566 )
At 31 October 2024 6,615,548

17. RELATED PARTY DISCLOSURES

Rent of £39,287 (2023: £34,800) was paid in the year to Celtic Chemicals (2005) Retirement Benefit Scheme. There was no outstanding balance at the year end.

Included in other creditors is an amount of £426,750 (2023: £469,425) in relation to accrued bonuses for the directors of the company.

18. ULTIMATE CONTROLLING PARTY

There is considered by the directors to be no ultimate controlling party of Celtic Chemicals Limited.